[go: up one dir, main page]

DK1758557T3 - Kvældbar doseringsform omfattende gellangummi - Google Patents

Kvældbar doseringsform omfattende gellangummi

Info

Publication number
DK1758557T3
DK1758557T3 DK05739537.8T DK05739537T DK1758557T3 DK 1758557 T3 DK1758557 T3 DK 1758557T3 DK 05739537 T DK05739537 T DK 05739537T DK 1758557 T3 DK1758557 T3 DK 1758557T3
Authority
DK
Denmark
Prior art keywords
dosage form
spindle
gellan gum
glucose
viscosity
Prior art date
Application number
DK05739537.8T
Other languages
English (en)
Inventor
Daniel Bar-Shalom
Lillian Slot
Gina Fischer
Pernille Hoeyrup Hemmingsen
Original Assignee
Egalet Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egalet Ltd filed Critical Egalet Ltd
Application granted granted Critical
Publication of DK1758557T3 publication Critical patent/DK1758557T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0023—Spoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0046—Cups, bottles or bags
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
DK05739537.8T 2004-05-11 2005-05-11 Kvældbar doseringsform omfattende gellangummi DK1758557T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200400755 2004-05-11
PCT/DK2005/000317 WO2005107713A2 (en) 2004-05-11 2005-05-11 Swellable dosage form comprising gellan gum

Publications (1)

Publication Number Publication Date
DK1758557T3 true DK1758557T3 (da) 2011-10-24

Family

ID=34967246

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05739537.8T DK1758557T3 (da) 2004-05-11 2005-05-11 Kvældbar doseringsform omfattende gellangummi
DK10175613.8T DK2258349T3 (da) 2004-05-11 2005-05-11 Kvældbar doseringsform omfattende gellangummi

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10175613.8T DK2258349T3 (da) 2004-05-11 2005-05-11 Kvældbar doseringsform omfattende gellangummi

Country Status (8)

Country Link
US (2) US8383154B2 (da)
EP (2) EP1758557B1 (da)
JP (1) JP5154924B2 (da)
AT (1) ATE516019T1 (da)
CA (1) CA2566793C (da)
DK (2) DK1758557T3 (da)
ES (2) ES2517244T3 (da)
WO (1) WO2005107713A2 (da)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060275366A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Controlled-release formulation
AU2006292672B2 (en) 2005-09-15 2012-04-19 Genzyme Corporation Sachet formulation for amine polymers
JP5507840B2 (ja) * 2005-09-19 2014-05-28 ユニバーシティ・オブ・ザ・ウィットウォータースランド・ヨハネスブルグ 口腔粘膜医薬投与形態
AU2008207200B2 (en) * 2007-01-16 2011-02-17 Egalet Ltd Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
US8563066B2 (en) 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
WO2009109194A2 (en) 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
US9237972B2 (en) * 2008-12-16 2016-01-19 Kimberly-Clark Worldwide, Inc. Liquid surfactant compositions that adhere to surfaces and solidify and swell in the presence of water and articles using the same
EP2208493A1 (en) * 2009-01-15 2010-07-21 Sandoz AG Method and device for oral application of a composition
AU2010206376B2 (en) * 2009-01-26 2012-10-18 Egalet Ltd. Controlled release formulations with continuous efficacy
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
AU2010211376B2 (en) 2009-02-06 2013-08-22 Egalet Ltd. Pharmaceutical compositions resistant to abuse
CN102348457A (zh) 2009-03-11 2012-02-08 奥默罗斯公司 预防和治疗成瘾的组合物和方法
NZ603579A (en) 2009-06-24 2014-02-28 Egalet Ltd Controlled release formulations
FR2955252B1 (fr) * 2010-01-21 2012-03-23 Patrick Lesage Materiau d'insertion destine a elargir le sillon gingival
US20130029030A1 (en) 2010-03-15 2013-01-31 Kristian Larsen Method for promotion of hemostasis and/or wound healing
MY162175A (en) * 2010-09-13 2017-05-31 Bev-Rx Inc Aqueous drug delivery system
US9132291B2 (en) 2010-10-05 2015-09-15 Dfb Technology, Ltd. Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
AU2012214553B2 (en) 2011-02-11 2015-07-09 Sociétés des Produits Nestlé S.A. Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
JP5226097B2 (ja) * 2011-03-30 2013-07-03 株式会社ファンケル サプリメントを内包する蓋体とサプリメント分散媒を充填したボトルからなるボトル入り飲料
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US8898912B2 (en) * 2011-08-29 2014-12-02 Adam Leffler Spoon delivery device
CA2852447A1 (en) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
WO2013095215A1 (en) * 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
EP2827839B1 (en) 2012-03-20 2019-02-27 Particle Dynamics International, LLC Gelling agent-based dosage form
WO2013169925A1 (en) * 2012-05-08 2013-11-14 Metronomx Novel formulations of nitrofurans including nifurtimox with enhanced activity with lower toxicity
JP6394916B2 (ja) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ／エス 乾燥止血組成物
NZ704011A (en) 2012-07-06 2016-04-29 Egalet Ltd Abuse deterrent pharmaceutical compositions for controlled release
EP2934422A4 (en) * 2012-12-23 2016-07-20 Vadim Zelikman RUBBER SUPPORT FOR A MEDICAMENT, MEDIUM AND METHOD
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
WO2014175917A1 (en) 2013-04-23 2014-10-30 Zx Pharma, Llc Multiparticulate-menthol formulations and related methods
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
EP2999462A4 (en) * 2013-06-26 2016-08-24 Univ Iowa Res Found DEVICE FOR ORAL DRUG ADMINISTRATION AND METHOD FOR USE THEREOF
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
LT3105218T (lt) 2014-02-13 2019-12-10 Incyte Corp Ciklopropilaminai kaip lsd1 inhibitoriai
EA201691594A1 (ru) 2014-02-13 2017-02-28 Инсайт Корпорейшн Циклопропиламины в качестве ингибиторов lsd1
WO2015168242A1 (en) * 2014-04-29 2015-11-05 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
CN105560281A (zh) * 2014-10-08 2016-05-11 华仁药业股份有限公司 一种混合糖电解质注射液及其制备方法
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
WO2016130908A1 (en) * 2015-02-13 2016-08-18 The University Of Toledo Therapeutic polysaccharide midi-gagr and related materials and methods
EP3626720A1 (en) 2015-04-03 2020-03-25 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
GR1008819B (el) 2015-05-22 2016-08-01 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου
JP6747651B2 (ja) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス 保管状態で真空を保持するための、及び２種の成分を混合するためのシリンジ
DK3334709T3 (da) 2015-08-12 2025-02-03 Incyte Holdings Corp Salte af en lsd1-hæmmer
US10342873B2 (en) 2016-05-06 2019-07-09 Physician's Seal, LLC Valerian composition and related methods
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10806789B2 (en) * 2017-05-12 2020-10-20 The LIV Group Inc. Composition for enhanced absorption of supplements
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
EP3699223A1 (de) * 2019-02-19 2020-08-26 LANXESS Deutschland GmbH Inline ultraschallkontrolle zur detektion des anvernetzens einer kautschukmischung bei der in situ silanisierung von hellen füllstoffen
CA3159407A1 (en) * 2019-10-28 2021-05-06 R.P. Scherer Technologies, Llc Delayed release softgel capsules in higher ph environment
JP2023533420A (ja) * 2020-07-10 2023-08-03 アデア ファーマシューティカルズ，インコーポレイテッド 膨潤性経口医薬組成物
US20240197635A1 (en) * 2021-03-03 2024-06-20 Veramorph Llc Dissociating polymer matrix compositions of fulvestrant and methods of their making and use
CN116133656A (zh) * 2021-09-09 2023-05-16 君德(新加坡)实验室有限公司 含脂肪酶抑制剂的高吸收性水凝胶
WO2024064359A2 (en) * 2022-09-25 2024-03-28 Albert Ludwig University Of Freiburg Marine polysaccharide networks
CN116449023B (zh) * 2023-04-10 2024-07-12 浙江伊利康生物技术有限公司 一种血清淀粉样蛋白a检测试剂盒及其制备方法
GB2630304A (en) * 2023-05-22 2024-11-27 Gelteq Ltd Pharmaceutical formulations
WO2025046044A1 (en) 2023-09-01 2025-03-06 F. Hoffmann-La Roche Ag Novel methods for preparing semi-solid compositions and uses thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994260A (en) 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
US4590075A (en) 1984-08-27 1986-05-20 Warner-Lambert Company Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation
US4824681A (en) 1986-12-19 1989-04-25 Warner-Lambert Company Encapsulated sweetener composition for use with chewing gum and edible products
GB8702411D0 (en) 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
AU1241192A (en) 1990-12-17 1992-07-22 Brian Butcher Microencapsulated sweeteners for use in baked goods
US5126151A (en) 1991-01-24 1992-06-30 Warner-Lambert Company Encapsulation matrix
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
PT893992E (pt) * 1996-04-16 2004-06-30 Novartis Consumer Health Sa Formas de dosagem oral de desintegracao rapida
WO1998006385A1 (de) 1996-08-15 1998-02-19 Losan Pharma Gmbh Gut schluckbare orale arzneiform
JP2001508411A (ja) * 1996-11-29 2001-06-26 モンサント・カンパニー 生物学的活性成分の経口投与のための潤滑性自立型（インタクト）ゲル
AU747099B2 (en) * 1997-10-31 2002-05-09 Pharmacia Corporation Gellan gum tablet coating
JP3524359B2 (ja) 1997-12-26 2004-05-10 伊那食品工業株式会社 咀嚼・嚥下困難者用の摂食補助用糊料
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
SK284948B6 (sk) 2000-04-06 2006-03-02 Zentiva, A. S. Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6474418B2 (en) 2000-12-07 2002-11-05 Frank's International, Inc. Wellbore fluid recovery system and method
EP1353649A2 (en) * 2000-12-21 2003-10-22 Oscar M. Bassinson Personal medication dispensing card
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
CN100364515C (zh) * 2001-09-28 2008-01-30 麦克内尔-Ppc股份有限公司 具有不同形状内核和外壳的剂型
ES2201932B2 (es) 2001-11-23 2005-03-16 Glaxo Group Limited Composicion farmaceutica.
JP3835544B2 (ja) * 2002-09-10 2006-10-18 明治乳業株式会社 ゼリー乾燥物
MXPA05011538A (es) 2003-04-25 2007-10-18 Reckitt Benckiser Healthcare Composiciones espesables.
WO2005007074A2 (en) 2003-07-21 2005-01-27 Bio-Dar Ltd. Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention
US9109434B2 (en) 2013-06-09 2015-08-18 Schlumberger Technology Corporation System and method for estimating oil formation volume factor downhole

Also Published As

Publication number Publication date
ES2370729T3 (es) 2011-12-22
WO2005107713A3 (en) 2006-05-18
ES2517244T3 (es) 2014-11-03
EP2258349B1 (en) 2014-07-16
CA2566793C (en) 2013-07-16
EP2258349A3 (en) 2012-04-04
US8383154B2 (en) 2013-02-26
CA2566793A1 (en) 2005-11-17
US8383155B2 (en) 2013-02-26
DK2258349T3 (da) 2014-10-13
US20080299199A1 (en) 2008-12-04
US20120039969A1 (en) 2012-02-16
JP2007537169A (ja) 2007-12-20
ATE516019T1 (de) 2011-07-15
EP1758557A2 (en) 2007-03-07
JP5154924B2 (ja) 2013-02-27
WO2005107713A2 (en) 2005-11-17
EP2258349A2 (en) 2010-12-08
EP1758557B1 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
DK2258349T3 (da) Kvældbar doseringsform omfattende gellangummi
US20210361822A1 (en) Functional wound dressing
EP3643328A1 (en) Ph-triggered diagnostic wound dressing
Vashist et al. Interpenetrating biopolymer network based hydrogels for an effective drug delivery system
EP2249884B1 (en) Adhering bandage and methods of applying the same
CN102559139B (zh) 密封轮胎穿孔的密封剂组合物及其制备方法
EP3643330A1 (en) Ph-triggered buffered wound dressing
JP2007502269A (ja) 温度感応性状態変化ハイドロゲル組成物及びその製造方法
BRPI0907965B1 (pt) produto para instalações sanitárias, seus usos e conjunto de limpeza para vaso sanitário compreendendo o mesmo
KR870007693A (ko) 경조직의 프라이밍(priming) 방법
Silva et al. Dissolvable carboxymethylcellulose microneedles for noninvasive and rapid administration of diclofenac sodium
EP2416741A1 (en) In situ gelling alginate systems
JP2014529339A (ja) 新規止血組成物
Cholewinski et al. Glycerol-stabilized algae–mussel-inspired adhesives for underwater bonding
AU2004212746B2 (en) Bioadhesive liquid composition which is substantially free of water
Huang et al. Biodegradable underwater tissue adhesive enabled by dynamic poly (thioctic acid) network
Bartkowiak et al. Study of viscoelastic, sorption and mucoadhesive properties of selected polymer blends for biomedical applications
CN103707587B (zh) 多层peg-dma水凝胶的制备方法
BR112018071272B1 (pt) Hidrogel (met)acrílico, método para produzir o referido hidrogel (met)acrílico, método para vedação e/ou preenchimento de fissuras, espaços vazios, falhas e cavidades em uma estrutura de construção
Viyoch et al. Formulation and development of a patch containing tamarind fruit extract by using the blended chitosan–starch as a rate‐controlling matrix
Sosnowska et al. The effect of PAMAM dendrimers with amine or hydroxyl terminal groups on the bioadhesive properties of hydrogels with clotrimazole
WO2021165558A1 (es) Capsula galénica rompible
CN104356403A (zh) 一种多孔木质素水凝胶的制备方法
KR20160101957A (ko) 제어가능하게 분해가능한 조성물 및 방법
US2614962A (en) Pharmaceutical composition for use in the treatment of keratin